{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:52:03Z","timestamp":1758797523672,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ypmed.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T12:47:13Z","timestamp":1452516433000},"page":"32-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Does IMPROVE-IT prove it?"],"prefix":"10.1016","volume":"85","author":[{"given":"Robert","family":"DuBroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2016.01.004_bb0005","doi-asserted-by":"crossref","first-page":"f6123","DOI":"10.1136\/bmj.f6123","article-title":"Should people at low risk of cardiovascular disease take a statin?","volume":"347","author":"Abramson","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0010","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2014.06.1190","article-title":"Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men. A population-based prospective cohort study","volume":"64","author":"\u00c5kesson","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0015","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care","volume":"288","author":"ALLHAT-LLT authors","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0020","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Anon","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2005.02.089","article-title":"Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial","volume":"46","author":"Arad","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0030","first-page":"1","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb (review)","volume":"4","author":"Aung","year":"2007","journal-title":"Cochrane Library"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"5262","key":"10.1016\/j.ypmed.2016.01.004_bb0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.272.5262.629","article-title":"Heart attacks: gone with the century?","volume":"272","author":"Brown","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0045","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2016.01.004_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2011.907","article-title":"Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women","volume":"306","author":"Chiuve","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomized trials","volume":"380","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ypmed.2016.01.004_bb0060","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M13-1788","article-title":"Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis","volume":"160","author":"Chowdhury","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0065","series-title":"Sham Science and Bad Medicine","article-title":"Cholesterol and Statins","author":"de Lorgeril","year":"2014"},{"key":"10.1016\/j.ypmed.2016.01.004_bb9000","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0140-6736(94)92580-1","article-title":"Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease","volume":"343","author":"de Lorgeril","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0070","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ypmed.2016.01.004_bb0075","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0080","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.39136.682083.AE","article-title":"Problems with use of composite end points in cardiovascular trials: systemic review of randomized controlled trials","volume":"334","author":"Ferreira-Gonz\u00e1lez","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0085","first-page":"810","article-title":"Results of the low-dose (20mg) Pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?","volume":"1","author":"GISSI Prevenzione Investigators","year":"2000","journal-title":"Ital. Heart J."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0090","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial","volume":"372","author":"GISSI-HF investigators","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ypmed.2016.01.004_bb0100","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0105","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jama.295.6.655","article-title":"Low-fat dietary pattern and risk of cardiovascular disease. The Women's Health Initiative Randomized Controlled Dietary Modification Trial","volume":"295","author":"Howard","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ypmed.2016.01.004_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","article-title":"Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Study","volume":"90","author":"Kannel","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0120","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0125","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"year":"1970","series-title":"The Structure of Scientific Revolutions","author":"Kuhn","key":"10.1016\/j.ypmed.2016.01.004_bb0130"},{"issue":"6","key":"10.1016\/j.ypmed.2016.01.004_bb0135","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.99.6.733","article-title":"Dietary prevention of coronary heart disease: the Lyon Diet Heart Study","volume":"99","author":"Leaf","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0140","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of CV events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"LIPID Study Group","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ypmed.2016.01.004_bb0150","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jacc.2012.01.045","article-title":"Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events","volume":"59","author":"Michos","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.ypmed.2016.01.004_bb0155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archinternmed.2010.182","article-title":"Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants","volume":"170","author":"Ray","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0160","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in Elderly Individuals at Risk of Vascular Disease (PROSPER): a randomized controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ypmed.2016.01.004_bb0165","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3945\/ajcn.2010.29673","article-title":"Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systemic review and meta-analysis","volume":"92","author":"Sofi","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0170","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0175","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial","volume":"366","author":"The FIELD Study Investigators","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","author":"The Post Coronary Artery Bypass Graft Trial Investigators","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2016.01.004_bb0185","first-page":"1","article-title":"Statins for acute coronary syndrome (review)","volume":"9","author":"Vale","year":"2014","journal-title":"Cochrane Library"},{"key":"10.1016\/j.ypmed.2016.01.004_bb0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N. Engl. J. Med."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743516000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743516000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:00:50Z","timestamp":1758794450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743516000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":38,"alternative-id":["S0091743516000050"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2016.01.004","relation":{},"ISSN":["0091-7435"],"issn-type":[{"type":"print","value":"0091-7435"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does IMPROVE-IT prove it?","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}